The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Protein-Based Nanoparticles as Drug Delivery Systems
Open accessAbstract
Nanoparticles have been extensively used as carriers for the delivery of chemicals and biomolecular drugs, such as anticancer drugs and therapeutic proteins. Natural biomolecules, such as proteins, are an attractive alternative to synthetic polymers commonly used in nanoparticle formulation because of their safety. In general, protein nanoparticles offer many advantages, such as biocompatibility and biodegradability. Moreover, the preparation of protein nanoparticles and the corresponding encapsulation process involved mild conditions without the use of toxic chemicals or organic solvents. Protein nanoparticles can be generated using proteins, such as fibroins, albumin, gelatin, gliadine, legumin, 30Kc19, lipoprotein, and ferritin proteins, and are prepared through emulsion, electrospray, and desolvation methods. This review introduces the proteins used and methods used in generating protein nanoparticles and compares the corresponding advantages and disadvantages of each.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449 · cited 1×
“artery-related diseases using the statin drug [99].”
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087481.55887.c9 · Cited by 2,668
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087480.94275.97 · Cited by 2,270
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,891
Polymer nanoparticles: Preparation techniques and size-control parameters
Rao, J. P., & Geckeler, K. E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.001 · Cited by 1,725
The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin
SUDLOW, G., BIRKETT, D. J., & WADE, D. N. (1975) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10691-3 · Cited by 1,725
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547 · cited 1×
“In the case of HDL-cholesterol levels, they have shown an inverse correlation with the risk of cardiovascular-related diseases [102].”
BackgroundAlbumin-based nanoparticles as potential controlled release drug delivery systems
Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.031 · Cited by 1,520
Nanoconfinement controls stiffness, strength and mechanical toughness of β-sheet crystals in silk
Keten, S., Xu, Z., Ihle, B., & Buehler, M. J. (2010) · Nature Materials · doi:10.1038/nmat2704 · Cited by 1,391
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Mohanraj, V. J., & Chen, Y. (2007) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v5i1.14634 · Cited by 1,217
Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers
Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.022 · Cited by 1,206
The extraordinary ligand binding properties of human serum albumin
Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., Notari, S., & Ascenzi, P. (2005) · IUBMB Life (International Union of Biochemistry and Molecular Biology: Life) · doi:10.1080/15216540500404093 · Cited by 1,086
Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport
Rosenson, R. S., Brewer, H. B., Davidson, W. S., Fayad, Z. A., Fuster, V., Goldstein, J., Hellerstein, M., Jiang, X.-C., Phillips, M. C., Rader, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.066589 · Cited by 953
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
Ventola, C. L. (2017) · Europe PMC (PubMed Central) · Cited by 835
Impact of albumin on drug delivery — New applications on the horizon
Elsadek, B., & Kratz, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 832
Mineralization in ferritin: an efficient means of iron storage
Chasteen, N. D., & Harrison, P. M. (1999) · Journal of Structural Biology · doi:10.1006/jsbi.1999.4118 · Cited by 815 · cited 1×
“There are two classes of ferritin (H and L) in mammalian cells, which function complementarily in relation to one another in the iron absorption process [108].”
BackgroundSilk fibroin as biomaterial for bone tissue engineering
Melke, J., Midha, S., Ghosh, S., Ito, K., & Hofmann, S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.005 · Cited by 789
Optimization of the preparation process for human serum albumin (HSA) nanoparticles
Langer, K., Balthasar, S., Vogel, V., Dinauer, N., von Briesen, H., & Schubert, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00134-0 · Cited by 757
Magnetoferritin nanoparticles for targeting and visualizing tumour tissues
Fan, K., Cao, C., Pan, Y., Lu, D., Yang, D., Feng, J., Song, L., Liang, M., & Yan, X. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.90 · Cited by 753
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
Lohcharoenkal, W., Wang, L., Chen, Y. C., & Rojanasakul, Y. (2014) · BioMed Research International · doi:10.1155/2014/180549 · Cited by 655
Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research
Elzoghby, A. O. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.019 · Cited by 651
Jalili, N., & Laxminarayana, K. (2004) · Mechatronics · doi:10.1016/j.mechatronics.2004.04.005 · Cited by 610
Desolvation process and surface characterisation of protein nanoparticles
Weber, C., Coester, C., Kreuter, J., & Langer, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00370-1 · Cited by 603
Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591
Biopolymer based nanomaterials in drug delivery systems: A review
Jacob, J., Haponiuk, J. T., Thomas, S., & Gopi, S. (2018) · Materials Today Chemistry · doi:10.1016/j.mtchem.2018.05.002 · Cited by 573
Controlling silk fibroin particle features for drug delivery
Lammel, A. S., Hu, X., Park, S.-H., Kaplan, D. L., & Scheibel, T. R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.024 · Cited by 538
Liang, M., Fan, K., Zhou, M., Duan, D., Zheng, J., Yang, D., Feng, J., & Yan, X. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407808111 · Cited by 507
Franceschini, G., Sirtori, C. R., Capurso, A., Weisgraber, K. H., & Mahley, R. W. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109956 · Cited by 472
Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469
Dunne, M., Corrigan, O. I., & Ramtoola, Z. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00040-5 · Cited by 444
Duivenvoorden, R., Tang, J., Cormode, D. P., Mieszawska, A. J., Izquierdo-Garcia, D., Ozcan, C., Otten, M. J., Zaidi, N., Lobatto, M. E., van Rijs, S. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4065 · Cited by 442
Redhead, H. M., Davis, S. S., & Illum, L. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00367-9 · Cited by 419
Regulatory aspects on nanomedicines
Sainz, V., Conniot, J., Matos, A. I., Peres, C., Zupanǒiǒ, E., Moura, L., Silva, L. C., Florindo, H. F., & Gaspar, R. S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.023 · Cited by 417
Choi, Y. H., & Han, H.-K. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0370-4 · Cited by 406
Nano spray drying: A novel method for preparing protein nanoparticles for protein therapy
Lee, S. H., Heng, D., Ng, W. K., Chan, H.-K., & Tan, R. B. H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.012 · Cited by 405
Targeting of Cancer Cells with Ferrimagnetic Ferritin Cage Nanoparticles
Uchida, M., Flenniken, M. L., Allen, M., Willits, D. A., Crowley, B. E., Brumfield, S., Willis, A. F., Jackiw, L., Jutila, M., Young, M. J., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0655690 · Cited by 395
Silk-based delivery systems of bioactive molecules
Numata, K., & Kaplan, D. L. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.009 · Cited by 385
HDL-targeted therapies: progress, failures and future
Kingwell, B. A., Chapman, M. J., Kontush, A., & Miller, N. E. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4279 · Cited by 354
Bertucci, C., & Domenici, E. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023369673 · Cited by 354
Silk Fibroin-Based Nanoparticles for Drug Delivery
Zhao, Z., Li, Y., & Xie, M.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16034880 · Cited by 332
Bock, N., Woodruff, M. A., Hutmacher, D. W., & Dargaville, T. R. (2011) · Polymers · doi:10.3390/polym3010131 · Cited by 326
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z. (., & Shin, D. M. (2009) · Nanoscience and Technology · doi:10.1142/9789814287005_0025 · Cited by 321
The Amphipathic α Helix: A Multifunctional Structural Motif in Plasma Apolipoproteins
Segrest, J. P., Garber, D. W., Brouillette, C. G., Harvey, S. C., & Anantharamaiah, G. M. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60643-9 · Cited by 311
Kim, T. H., Jiang, H. H., Youn, Y. S., Park, C. W., Tak, K. K., Lee, S., Kim, H., Jon, S., Chen, X., & Lee, K. C. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.041 · Cited by 293
Self-citationComposition and Structure of Whey Protein/Gum Arabic Coacervates
Weinbreck, F., Tromp, R. H., & de Kruif, C. G. (2004) · Biomacromolecules · doi:10.1021/bm049970v · Cited by 289
Adams, S., Diamond, J. R., Hamilton, E., Pohlmann, P. R., Tolaney, S. M., Chang, C.-W., Zhang, W., Iizuka, K., Foster, P. G., Molinero, L., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5152 · Cited by 288
Nano- and microparticles for the delivery of polypeptides and proteins
Couvreur, P., & Puisieux, F. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90046-7 · Cited by 281
Patel, Z. S., Yamamoto, M., Ueda, H., Tabata, Y., & Mikos, A. G. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.04.002 · Cited by 279
Calcium Orthophosphates as Bioceramics: State of the Art
Dorozhkin, S. V. (2010) · Journal of Functional Biomaterials · doi:10.3390/jfb1010022 · Cited by 278
Zhen, Z., Tang, W., Guo, C., Chen, H., Lin, X., Liu, G., Fei, B., Chen, X., Xu, B., & Xie, J. (2013) · ACS Nano · doi:10.1021/nn402199g · Cited by 272
Recent advancement of gelatin nanoparticles in drug and vaccine delivery
Sahoo, N., Sahoo, R. K., Biswas, N., Guha, A., & Kuotsu, K. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.006 · Cited by 270
Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization
Zhang, Y.-Q., Shen, W.-D., Xiang, R.-L., Zhuge, L.-J., Gao, W.-J., & Wang, W.-B. (2007) · Journal of Nanoparticle Research · doi:10.1007/s11051-006-9162-x · Cited by 261
A simple improved desolvation method for the rapid preparation of albumin nanoparticles
Jahanban-Esfahlan, A., Dastmalchi, S., & Davaran, S. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.05.032 · Cited by 254
Protein Based Nanostructures for Drug Delivery
Verma, D., Gulati, N., Kaul, S., Mukherjee, S., & Nagaich, U. (2018) · Journal of Pharmaceutics · doi:10.1155/2018/9285854 · Cited by 244
Zheng, G., Chen, J., Li, H., & Glickson, J. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508677102 · Cited by 226
Low-Density Lipoprotein as a Vehicle for Targeting Antitumor Compounds to Cancer Cells
Firestone, R. A. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00026a002 · Cited by 225
Song, Q., Huang, M., Yao, L., Wang, X., Gu, X., Chen, J., Chen, J., Huang, J., Hu, Q., Kang, T., et al. (2014) · ACS Nano · doi:10.1021/nn4058215 · Cited by 219 · cited 1×
“Lipoprotein nanoparticles have been used for the treatment of Alzheimer’s disease [97].”
MethodAlbumin microspheres for study of the reticuloendothelial system.
Scheffel, U., Rhodes, B. A., Natarajan, T. K., & Wagner, H. N. (1972) · PubMed · Cited by 207
Fibroin nanoparticles: a promising drug delivery system
Pham, D. T., & Tiyaboonchai, W. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1736208 · Cited by 193
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles
Mishra, V., Mahor, S., Rawat, A., Gupta, P. N., Dubey, P., Khatri, K., & Vyas, S. P. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600612953 · Cited by 191
YANG, L., CUI, F., CUN, D., TAO, A., SHI, K., & LIN, W. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.028 · Cited by 190
Wang, H., Zou, Q., Boerman, O. C., Nijhuis, A. W. G., Jansen, J. A., Li, Y., & Leeuwenburgh, S. C. G. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.015 · Cited by 189
Human serum albumin–polyethylenimine nanoparticles for gene delivery
Rhaese, S., von Briesen, H., Rübsamen-Waigmann, H., Kreuter, J., & Langer, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00302-x · Cited by 180
Sabra, S. A., Elzoghby, A. O., Sheweita, S. A., Haroun, M., Helmy, M. W., Eldemellawy, M. A., Xia, Y., Goodale, D., Allan, A. L., & Rohani, S. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.04.023 · Cited by 170
Controlled Gene Delivery by DNA–Gelatin Nanospheres
Truong-Le, V. L., August, J. T., & Leong, K. W. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.12-1709 · Cited by 169
Albumin Nanospheres as Carriers for Passive Drug Targeting: An Optimized Manufacturing Technique
Müller, B. G., Leuenberger, H., & Kissel, T. (1996) · Pharmaceutical Research · doi:10.1023/a:1016064930502 · Cited by 159
Gianni, L., Mansutti, M., Antón, A., Calvo, L., Bisagni, G., Bermejo, B., Семиглазов, В. Ф., Thill, M., Chacón, J. I., Chan, A., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.4612 · Cited by 156
Lipoproteins and lipoprotein mimetics for imaging and drug delivery
Thaxton, C. S., Rink, J. S., Naha, P. C., & Cormode, D. P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.020 · Cited by 152
Nanomedicines: from bench to bedside and beyond.
Havel, H., Finch, G., Strode, P., Wolfgang, M., Zale, S., Bobe, I., Youssoufian, H., Peterson, M., & Liu, M. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9961-7 · Cited by 149
Azarmi, S., Huang, Y., Chen, H., McQuarrie, S. A., Abrams, D. N., Roa, W., Finlay, W. H., Miller, G. G., & Löbenberg, R. (2006) · PubMed · Cited by 145
Gong, J., Huo, M., Zhou, J., Zhang, Y., Peng, X., Yu, D., Zhang, H., & Li, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.033 · Cited by 137
Mistry, A., Glud, S. Z., Kjems, J., Randel, J., Howard, K. A., Stolnik, S., & Illum, L. (2009) · Journal of drug targeting · doi:10.1080/10611860903055470 · Cited by 137
Saleh, T., Soudi, T., & Shojaosadati, S. A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.129 · Cited by 130
Wang, G., & Uludağ, H. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.5.499 · Cited by 126
Umamaheshwari, R. B., Ramteke, S., & Jain, N. K. (2004) · AAPS PharmSciTech · doi:10.1208/pt050232 · Cited by 125
Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery
Damiano, M. G., Mutharasan, R. K., Tripathy, S., McMahon, K. M., & Thaxton, C. S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.013 · Cited by 124
Silk fibroin nanoparticles: Efficient vehicles for the natural antioxidant quercetin
Pérez, A. A. L., Rivero, H. C., Hernández, M. D. C. P., Pagán, A., Montalbán, M. G., Víllora, G., & Cenís, J. L. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.046 · Cited by 121
Mottaghitalab, F., Kiani, M., Farokhi, M., Kundu, S. C., Reis, R. L., Gholami, M., Bardania, H., Dinarvand, R., Geramifar, P., Beiki, D., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b10408 · Cited by 119
Modified gelatin nanoparticles for gene delivery
Madkhali, O. A. A., Mekhail, G. M., & Wettig, S. D. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.001 · Cited by 119
Reconstituted Lipoprotein: A Versatile Class of Biologically-Inspired Nanostructures
Bricarello, D. A., Smilowitz, J. T., Zivkovic, A. M., German, J. B., & Parikh, A. N. (2010) · ACS Nano · doi:10.1021/nn103098m · Cited by 118
Han, J., Kang, Y. J., Shin, C., Ra, J.-S., Shin, H., Hong, S. Y., Do, Y., & Kang, S. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.11.003 · Cited by 116
Self-citationPolymer Micelles as Drug Carriers
Batrakova, E. V., Bronich, T. K., Vetro, J. A., & Kabanov, A. V. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860949074_0005 · Cited by 112
Silica nanoparticle stability in biological media revisited
Yang, S.-A., Choi, S., Jeon, S. M., & Yu, J. (2018) · Scientific Reports · doi:10.1038/s41598-017-18502-8 · Cited by 107
Havel, H. A. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9970-6 · Cited by 99
Phạm, D. T., Saelim, N., & Tiyaboonchai, W. (2018) · Journal of Materials Science · doi:10.1007/s10853-018-2635-3 · Cited by 99
Wang, S., Xu, T., Yang, Y., & Shao, Z. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b05335 · Cited by 98
Fabrication of Gold Nanoparticles Inside Unmodified Horse Spleen Apoferritin
Fan, R., Chew, S. W., Cheong, V. V., & Orner, B. P. (2010) · Small · doi:10.1002/smll.201000457 · Cited by 94
Gelatin Nanoparticles and Their Biofunctionalization
Kommareddy, S., Shenoy, D. B., & Amiji, M. M. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0011 · Cited by 92
Haggag, Y. A., & Faheem, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00140 · Cited by 91
Gálvez, J., Rodríguez‐Nogales, A., Ortiz, V., Algieri, F., Zorrilla, P., Rodríguez‐Cabezas, M. E., Garrido‐Mesa, N., Utrilla, M. P., Matteis, L. D., Garrido‐Mesa, J., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s68526 · Cited by 91
Food-Grade Protein-Based Nanoparticles and Microparticles for Bioactive Delivery
Davidov‐Pardo, G., Joye, I. J., & McClements, D. J. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2014.11.004 · Cited by 90
Steinhauser, I. M., Langer, K., Strebhardt, K., & Spänkuch, B. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.001 · Cited by 90
Antibiotic delivery polyurethanes containing albumin and polyallylamine nanoparticles
Crisante, F., Francolini, I., Bellusci, M., Martinelli, A., D’Ilario, L., & Piozzi, A. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.12.006 · Cited by 87
Liang, H., Huang, Q., Zhou, B., He, L., Lin, L., An, Y., Li, Y., Liu, S., Chen, Y., & Li, B. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb01920b · Cited by 86
Ezpeleta, I., Arangoa, M. A., Irache, J. M., Stainmesse, S., Chabenat, C., Popineau, Y., & Orecchioni, A. M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00232-x · Cited by 85
Jameson, G., Borazanci, E. H., Babiker, H. M., Poplin, E. A., Niewiarowska, A. A., Gordon, M. S., Barrett, M. T., Rosenthal, A., Stoll-D'Astice, A. C., Crowley, J. J., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3394 · Cited by 83
Nisha, C. K., Manorama, S. V., Ganguli, M., Maiti, S., & Kizhakkedathu, J. N. (2004) · Langmuir · doi:10.1021/la035737r · Cited by 81
Gelatin nanospheres incorporating siRNA for controlled intracellular release
Ishikawa, H., Nakamura, Y., Jo, J., & Tabata, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.032 · Cited by 79
Mimi, H., Ho, K. M., Siu, Y. S., Wu, A., & Li, P. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.035 · Cited by 79
Stabilization of Dichloromethane-Induced Protein Denaturation During Microencapsulation
Raghuvanshi, R. S., Goyal, S., Singh, O., & Panda, A. K. (1998) · Pharmaceutical Development and Technology · doi:10.3109/10837459809028504 · Cited by 76
Ninan, G., Joseph, J., & Abubacker, Z. A. (2010) · Journal of Food Processing and Preservation · doi:10.1111/j.1745-4549.2009.00467.x · Cited by 75
Human serum albumin nanoparticles for ocular delivery of bevacizumab
de Redín, I. L., Boiero, C., Martínez-Ohárriz, M. C., Agüeros, M., Ramos-Membrive, R., Peñuelas, I., Allemandi, D. A., Llabot, J. M., & Irache, J. M. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.02.003 · Cited by 75
Expression of MUC5AC in Ocular Surface Epithelial Cells Using Cationized Gelatin Nanoparticles
Zorzi, G. K., Contreras‐Ruiz, L., Párraga, J. E., López‐García, A., Bello, R. R., Diebold, Y., Seijo, B., & Sánchez, A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200155t · Cited by 72
Mao, J., Liu, S., Ai, M., Wang, Z., Wang, D., Li, X., Hu, K., Gao, X., & Yang, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0442-y · Cited by 65
Optimization and in vitro stability of legumin nanoparticles obtained by a coacervation method
Irache, J. M. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04103-6 · Cited by 64
Silk protein as a fascinating biomedical polymer: Structural fundamentals and applications
Ki, C. S., Park, Y. H., & Jin, H. (2009) · Macromolecular Research · doi:10.1007/bf03218639 · Cited by 62
Jahanshahi, M., Najafpour, G. D., & Rahimnejad, M. (2008) · doi:10.5897/ajb07.843 · Cited by 62
Chen, B., Kankala, R. K., He, G.-Y., Yang, D., Li, G., Wang, P., Wang, S., Zhang, Y. S., & Chen, A. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00705 · Cited by 61
Song, W., Gregory, D. A., Al‐Janabi, H., Muthana, M., Cai, Z., & Zhao, X. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.030 · Cited by 61
Peptide‐Modified Dendrimer Nanoparticles for Targeted Therapy of Colorectal Cancer
Carvalho, M. R., Carvalho, C. R., Maia, F. R., Caballero, D., Kundu, S. C., Reis, R. L., & Oliveira, J. M. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900132 · Cited by 60
Nazari, H., Heirani‐Tabasi, A., Hajiabbas, M., Bani, M. S., Nazari, M., Mahabadi, V. P., Rad, I., Kehtari, M., Tafti, S. H. A., & Soleimani, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29553 · Cited by 60
Ammonia as a case study for the spontaneous ionization of a simple hydrogen-bonded compound
Palasyuk, T., Troyan, I., Eremets, M., Drozd, V., Medvedev, S., Zaleski–Ejgierd, P., Magos–Palasyuk, E., Wang, H., Bonev, S. A., Dudenko, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms4460 · Cited by 58
Kushibiki, T., Tomoshige, R., Iwanaga, K., Kakemi, M., & Tabata, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.003 · Cited by 55
Ferroxidase-Mediated Iron Oxide Biomineralization: Novel Pathways to Multifunctional Nanoparticles
Zeth, K., Hoiczyk, E., & Okuda, M. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.11.011 · Cited by 55
Jabalera, Y., Garcia-Pinel, B., Ortiz, R., Iglesias, G., Cabeza, L., Prados, J., Jimenez-Lopez, C., & Melguizo, C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080395 · Cited by 49
Assembled protein nanoparticles in food or nutrition applications
Cho, Y.-H., & Jones, O. G. (2019) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2019.01.002 · Cited by 45
Wadbua, P., Promdonkoy, B., Maensiri, S., & Siri, S. (2010) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2010.03.007 · Cited by 39
Chou, M.-J., Yu, H.-Y., Hsia, J.-C., Chen, Y., Hung, T.-T., Chao, H., Chern, E., & Huang, Y. (2018) · Materials · doi:10.3390/ma11020301 · Cited by 34
Nanoparticle–Dendrimer Hybrid Nanocapsules for Therapeutic Delivery
Jeong, Y., Kim, S. T., Jiang, Y. Y., Duncan, B., Kim, C. S., Saha, K., Yeh, Y., Yan, B., Tang, R., Hou, S., et al. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0034 · Cited by 32
Lee, H. J., Park, H. H., Sohn, Y., Ryu, J., Park, J. H., Rhee, W. J., & Park, T. H. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7689-z · Cited by 32
Self-citationProtein‐stabilizing and cell‐penetrating properties of α‐helix domain of 30Kc19 protein
Ryu, J., Kim, H., Park, H. H., Lee, H. J., Park, J. H., Rhee, W. J., & Park, T. H. (2016) · Biotechnology Journal · doi:10.1002/biot.201600040 · Cited by 23
Self-citationMesken, J., Iltzsche, A., Mulac, D., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.03.006 · Cited by 19
Park, H. H., Sohn, Y., Yeo, J. W., Park, J. H., Lee, H. J., Ryu, J., Rhee, W. J., & Park, T. H. (2014) · Process Biochemistry · doi:10.1016/j.procbio.2014.05.008 · Cited by 17
Self-citationEmerging Roles of PCSK9: More Than a One-Trick Pony
Moore, K. J., & Goldberg, I. J. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306756 · Cited by 17
Fabrication and evaluation of gelatin nanoparticles for delivering of anti - cancer drug
Babaei, Z., Jahanshahi, M., & Sanati, M. H. (2008) · International journal of nanoscience and nanotechnology · Cited by 16
Pandey, V., Tiwari, N., Pandey, V. S., Rao, A., & Das, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816200-2.00012-8 · Cited by 16
Kim, W., Islam, R., Kim, B. S., Cho, Y., Yoon, W., Baek, J., Woo, K. M., & Ryoo, H. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25673 · Cited by 14
Enzyme delivery using protein-stabilizing and cell-penetrating 30Kc19α protein nanoparticles
Park, H. H., Woo, Y. H., Ryu, J., Lee, H. J., Park, J. H., & Park, T. H. (2017) · Process Biochemistry · doi:10.1016/j.procbio.2017.08.021 · Cited by 9
Self-citationThe Functional Structure of Human Serum Albumin
Junk, M. J. N. (2012) · Springer eBooks · doi:10.1007/978-3-642-25135-1_3 · Cited by 4
Cited by
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics
Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022) · Biomedicines · doi:10.3390/biomedicines10092055 · Cited by 704
Chen, Y., Tandon, I., Heelan, W., Wang, Y., Tang, W., & Hu, Q. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00762a · Cited by 315
Burlec, A. F., Corciova, A., Boev, M., Batir-Marin, D., Mircea, C., Cioanca, O., Danila, G., Danila, M., Bucur, A. F., & Hancianu, M. (2023) · Pharmaceuticals · doi:10.3390/ph16101410 · Cited by 295
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
Rodríguez, F., Caruana, P., De la Fuente, N., Español, P., Gámez, M., Balart, J., Llurba, E., Rovira, R., Ruiz, R., Martín-Lorente, C., et al. (2022) · Biomolecules · doi:10.3390/biom12060784 · Cited by 274
Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis
Singh, A., Chakraborty, S., Wong, S. W., Hefner, N. A., Stuart, A., Qadir, A. S., Mukhopadhyay, A., Bachmaier, K., Shin, J.-W., Rehman, J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121098119 · Cited by 107
Metadata
- Authors
- Hong, S., Choi, D. W., Kim, H. N., Park, C. G., Lee, W., & Park, H. H.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-06-29
- Volume
- 12
- Issue
- 7
- Pages
- 604
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W3037791971
- Cited by
- 619
- References
- 135
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.